The Tenecteplase Drug Market is expanding as healthcare providers emphasize rapid treatment for cardiovascular emergencies. Tenecteplase is a recombinant tissue plasminogen activator (tPA) designed to dissolve blood clots efficiently in patients experiencing acute myocardial infarction (AMI). Its ease of administration through a single intravenous bolus makes it a valuable option in emergency...